House Bill 2565
117th Congress(2021-2022)
FDA Modernization Act of 2021
Introduced
Introduced in House on Apr 15, 2021
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2565
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Vern Buchanan
grade
Florida
Alabama
Arizona
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
Colorado
Colorado
Connecticut
District of Columbia
Florida
Florida
Florida
Florida
Florida
Florida
Florida
Florida
Georgia
Illinois
Illinois
Illinois
Illinois
Iowa
Kentucky
Louisiana
Maine
Maine
Maryland
Massachusetts
Michigan
Michigan
Michigan
Michigan
Michigan
Minnesota
Nebraska
Nevada
Nevada
New Hampshire
New Hampshire
New Jersey
New Jersey
New Jersey
New Jersey
New Jersey
New Jersey
New Mexico
New York
New York
New York
New York
New York
New York
New York
New York
New York
New York
North Carolina
North Carolina
North Carolina
North Carolina
North Carolina
North Carolina
Ohio
Ohio
Ohio
Ohio
Oklahoma
Oklahoma
Oregon
Oregon
Oregon
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
South Carolina
Tennessee
Tennessee
Tennessee
Texas
Texas
Texas
Texas
Texas
Texas
Texas
Texas
Texas
Texas
Virginia
Virginia
Virginia
Wisconsin
Wisconsin
No House votes have been held for this bill.
Summary
FDA Modernization Act of 2021
This bill allows an applicant for market approval for a new drug to use methods other than animal testing to establish the drug's safety and effectiveness. Under this bill, these alternative methods may include cell-based assays, organ chips and microphysiological systems, sophisticated computer modeling, and other human biology-based test methods.
April 15, 2021
Sort by most recent
04/16/2021
Referred to the Subcommittee on Health.
04/15/2021
Referred to the House Committee on Energy and Commerce.
04/15/2021
Introduced in House
Public Record
Record Updated
Mar 8, 2023 7:58:48 PM